Treatment of active refractory rheumatoi
โ
Eric L. Matteson; David E. Yocum; E. William St. Clair; Antonio A. Achkar; Micha
๐
Article
๐
1995
๐
John Wiley and Sons
๐
English
โ 659 KB
Objective. To investigate the dose tolerance and potential clinical activity of a humanized antilymphocyte monoclonal antibody, CAMPATH-1H (ClH), in patients with active, refractory rheumatoid arthritis (RA). Methods. Thirty adult patients with active, refractory RA were treated in an open-label, 3